Imaging Pulmonary Inflammation
- PMID: 27587704
- PMCID: PMC5095507
- DOI: 10.2967/jnumed.115.157438
Imaging Pulmonary Inflammation
Abstract
Lung inflammatory diseases contribute significantly to the socioeconomic burden of disease. Yet very few new, effective therapies for respiratory disease have been approved for use. A major contributing factor is the lack of biomarkers that can accurately quantify the lung inflammatory burden and can be used to understand the contribution of lung inflammation to loss in lung function. Molecular imaging approaches can detect and quantify the recruitment and activation of specific immune cells in lung inflammation. We review the clinical techniques used to image lung inflammation, provide an overview of clinical and emerging PET techniques for quantifying lung inflammation, and discuss potential clinical applications.
Keywords: lung inflammation; molecular imaging; positron emission tomography; pulmonary.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Figures





References
-
- National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI). Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: NHLBI; 2012.
-
- Xu JQ, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. In: National Vital Statistics Reports. Vol. 64 Hyattsville, MD: National Center for Health Statistics; 2016. - PubMed
-
- Martinez FJ, Donohue JF, Rennard SI. The future of chronic obstructive pulmonary disease treatment: difficulties of and barriers to drug development. Lancet. 2011;378:1027–1037. - PubMed
-
- Adams CP, Brantner VV. Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood). 2006;25:420–428. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources